- Lonza Launches Innovaform™ Accelerator, the New Innovation and Formulation Center in Colmar (FR)
- Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
- Revolo Biotherapeutics Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104
- NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases
- Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
- Harnessing the Power of the Heart and Mind: Overcoming Atrial Fibrillation and Launching a Business | By Jim Kaveney
- Circular Genomics Announces Launch of MindLight, the 1st SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors.
Stay Ahead in Medical Technology
At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.
In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.
Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.
Stay informed, stay connected, and join us as we navigate the future of healthcare together.
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
Clinical Trials
Theranica Achieves Positive Results in Placebo-Controlled Pivotal Trial of Nerivio® for Preventive Treatment of Migraine
This trial evaluated the efficacy and safety of Nerivio® for the preventive treatment of migraine in both episodic and chronic migraine patients. The study met the primary endpoint, demonstrating a statistically significant reduction from baseline in monthly migraine days in patients treated with Nerivio®, compared with a placebo device.
1st Patient Enrolled in Early Feasibility Study, Evaluating Doraya Catheter for Relieving Congestion in Acute Heart Failure (AHF) Patient
The Doraya catheter is placed in the Inferior Vena Cava below the renal veins, applying partial adjustable flow for up to 12 hours.
Hollister Secure Start ℠ Services has a Measurable Impact
Hollister announced the publication of a patient support program study through the Journal of Wound Ostomy & Continence Nursing (JWOCN). The study, titled A Cross-Sectional Survey Reporting on the Value of Patient-Centered Ostomy Programs: A Smooth Transition After Ostomy Surgery, focuses on connecting support service interactions to better results in areas of stoma barrier leakage, proper fit, and skin health1
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Chronic Liver Disease: The ‘Silent’ Disease Affecting 1 in 3 People with An Annual Mortality Rate of 2 Million
Chronic liver disease is a major public health issue worldwide, affecting over 844 million people with an annual mortality rate of 2 million.
Addressing the Silent and Deadly Rise of CKD with Genetic Testing
CKD is a common and growing public health concern. The CDC estimates that one in seven American adults (roughly 37 million people) have CKD, and many are not aware they have it.
Large International Study Pinpoints the Impact of TP53 Mutations On Blood Cancer Severity
A large international study led by researchers at Memorial Sloan Kettering finds that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with worse outcomes in myelodysplastic syndrome and acute myeloid leukemia. The findings have immediate clinical relevance for risk assessment and treatment of people with a blood cancer called myelodysplastic syndrome
Executives on the Move
